Clinical trial

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or…

NCT00005977 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00005977
Title Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
Official title A Pilot Study of Dose Intensification of Methotrexate in Patients With Advanced-Stage (III/IV) Small Non-Cleaved Cell Non-Hodgkins Lymphoma and B-Cell All
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Leukemia, Lymphoma
Intervention type Biological, Drug
Interventions filgrastim, cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, methotrexate, vincristine sulfate
Enrollment 83
Start date Sep 1, 2000
Primary completion Mar 1, 2004
Completion Sep 1, 2006
First posted May 21, 2003
Last update posted Aug 21, 2013
Countries Australia, Canada, Netherlands, Puerto Rico, Switzerland, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies